Glaukos Corporation · 2 hours ago
Payer Relations Director
United States
Full-time
Remote
Director/Executive
$166K/yr - $216K/yr
15+ years expGlaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of eye diseases. The Payer Relations Director – West is responsible for managing coverage, coding, and reimbursement processes across various healthcare payers while collaborating with internal teams and stakeholders to support sales and drive favorable outcomes for products.
Health CareMedicalWellness
Responsibilities
Develop and execute strategies to secure and maintain coverage for new and existing products with PBMs, commercial payers, Medicare Advantage, and Medicaid
Partner with Sales, Reimbursement Liaison, and leadership teams to support KOL healthcare providers with reimbursement needs
Build sustainable relationships with payers, advocacy groups, and healthcare stakeholders
Analyze and interpret healthcare regulations and legislation
Travel required: 50%+ (3-4 nights/week)
Qualification
Required
15+ years of relevant industry experience
10+ years in payer medical devices and procedural pharmaceuticals; direct biologic launch and ophthalmology experience preferred
In-depth knowledge of buy and bill systems, reimbursement processes, and coding (T codes, J codes, appeals)
Experience with PBMs, health plans, Medicare Advantage, Medicaid, and account management
Minimum 2 years in practice management, billing, revenue cycle, or reimbursement in pharma/managed care
Bachelor's degree required
Strong communication, project management, and teamwork
Preferred
direct biologic launch and ophthalmology experience
advanced degree or practice management experience
Company
Glaukos Corporation
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$121MKey Investors
Meritech Capital PartnersOrbiMed
2015-06-25IPO
2013-02-07Series F· $30M
2012-10-03Debt Financing· $6M
Leadership Team
Alex Thurman
Senior Vice President and Chief Financial Officer
Joseph Gilliam
President & Chief Operating Officer
Recent News
Orange County Business Journal
2026-01-24
Orange County Business Journal
2026-01-22
Company data provided by crunchbase